Although CCL14 was reported to play a role in breast cancer and hepatocellular carcinoma progression as a prognostic biomarker (Li et al., 2011; Gu et al., 2020), CCL14 expression in the TME of gastric cancer is not fully known. The gene discussed is CCL14; the disease is hepatocellular carcinoma.